Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Topic: Sanofi

GSK & Sanofi Back for a Phase 2 Vaccine Trial in U.S., Honduras & Panama Financed by U.S. Gov

Two major European pharmaceutical manufacturers, France-based Sanofi and UK-based GlaxoSmithKline (GSK) found setbacks toward the end of 2020 with an […]

GSK & Sanofi Back for a Phase 2 Vaccine Trial in U.S., Honduras & Panama Financed by U.S. Gov
1 week ago
Share

Clinical Trials and Research Roundup | Doctors: Ivermectin Can Help Treat COVID: Will Anyone Listen?

  Introducing the Physicians for Civil Defense: Prominent Doctors Know #Ivermectin can Help Treat COVID-19: Will Anyone Listen?A group calling […]

Doctors: Ivermectin Can Help Treat COVID: Will Anyone Listen?
3 months ago
Share

Sanofi & GSK Vaccine Reagent Mistake Will Cost Hundreds of Millions & 4-5 Month Delay During Pandemic

An incredibly costly mistake will delay the Sanofi SA and GlaxoSmithKline PLC COVID-19 vaccine by several months, complicating plans by […]

Sanofi & GSK Vaccine Reagent Mistake Will Cost Hundreds of Millions & 4-5 Month Delay During Pandemic
3 months ago
Share

Sanofi & Regeneron Phase III Lung Cancer Drug Trial Stopped Early Due to Significant Improvement in Overall Survival

Although Sanofi and Regeneron are not in the current PD-1/PD-L1 market mix they are scrambling to be with Libtayo (cemiplimab) […]

Sanofi & Regeneron Phase III Lung Cancer Drug Trial Stopped Early Due to Significant Improvement in Overall Survival
10 months ago
Share

Regeneron & Sanofi Amend Phase II/III Kevzara COVID-19 Clinical Trial—Only Focus on Critical Patients

An Independent Data Monitoring Committee (IDMC) suggested that Regeneron and Sanofi only continue the ongoing Phase II/III clinical trial for […]

Regeneron & Sanofi Amend Phase IIIII Kevzara COVID-19 Clinical Trial—Only Focus on Critical Patients
10 months ago
Share

Sanofi & GSK Ink LOI to Commence COVID-19 Vaccine Collaboration: Finished Good Projected for 14+ Months Away

European pharmaceutical giants recently inked a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from […]

Sanofi & GSK Ink LOI to Commence COVID-19 Vaccine Collaboration Finished Good Projected for 14+ Months Away
11 months ago
Share

University of Buffalo Commences Sarilumab Clinical Trial for those COVID-19 Patients at Risk for Cytokine Storm

University of Buffalo (UB) and Roswell Park Comprehensive Cancer Center received the greenlight from the U.S. Food and Drug Administration […]

University of Buffalo Commences Sarilumab Clinical Trial for those COVID-19 Patients at Risk for Cytokine Storm
11 months ago
Share

Regeneron & Sanofi Gear Up for Global Clinical Trial Targeting COVID-19 Symptoms

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi announced the partners have commenced a clinical program evaluating Kevzara® (sarilumab) in patients […]

Regeneron & Sanofi Gear Up for Global Clinical Trial Targeting COVID-19 Symptoms
12 months ago
Share

Sanofi Backs Out of $1.7 Billion Deal With Lexicon Pharmaceuticals—Stock Drops 66%

Up to a $1.7 billion collaboration was terminated when Sanofi canceled an agreement with Lexicon Pharmaceuticals to develop Zynquista™ (sotagliflozin) after […]

Sanofi Backs Out of $1.7 Billion Deal With Lexicon Pharmaceuticals—Stock Drops 66%
2 years ago
Share

SiteWatch: Up to 48 Years in Prison for Philippines Investigator Involved with Dengue Vaccine Sponsored by Sanofi Pasteur

Fatima Arkin of Science writes that a prominent pediatrician and investigator in the Philippines was indicted over the failed and […]

2 years ago
Share

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.